Jump to content
  • Sign Up
0
Scott Adams

BioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010 ... - The Herald | HeraldOnline.com

Rate this topic

Recommended Posts

BioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010 ...

The Herald | HeraldOnline.com

JERUSALEM — BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that BL-7010, an orally available treatment for celiac disease, was found to be safe and well tolerated in pre-clinical studies ...

BioLineRx Reports Pre-clinical Results Related To BL-7010 NASDAQ

all 8 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×